Intravesical Bacillus Calmette–Guerin (BCG)—A Survey of Practice Patterns of Urologists Across Britain and Ireland

References

• Morales , A , Eidinger , D and Bruce , AW . 1976 . Intracavitary Bacillus Calmette–Guerin in the treatment of superficial bladder tumours . J. Urol. , 116 : 180 – 183 .
   PubMed Web of Science ®Google Scholar
• Oosterlinck , W , Lobel , B , Jakse , G , Malmstrom , PU , Stockle , M and Sternberg , C . 2002 . European Association of Urology (EAU) Working Group on Oncological Urology: guidelines on bladder cancer . Eur. Urol. , 41 : 105 – 112 .
   PubMed Web of Science ®Google Scholar
• Bohle A Jocham D 2000 Immunotherapy with BCG—Facts Figures and Results Urdan & Fischer Munchen
   Google Scholar
• Sylvester , RJ , van der Meijden , APM and Lamm , DL . 2002 . Intravesical Bacillus Calmette–Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomised clinical trials . J. Urol. , 168 : 1964 – 1970 .
   PubMed Web of Science ®Google Scholar
• Comparison of proportions (StataCorp.2001.Statistical Software: Release 7.0. College-Station, TX: StataCorporation.)
   Google Scholar
• Lamm DL Blumenstein BA Crissman JD et al. 2000 Maintenance Bacillus Calmette–Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ J. Urol. 163 1124 1129
   PubMed Web of Science ®Google Scholar
• Thomas , DFM and Fraser , M . 2001 . The role of the adult urologist in the care of children findings of a UK survey . BJU Int. , 88 : 80 – 83 .
   Google Scholar
• Anonymous 1999 ‘Extremes of Age’ The Report of the National Confidential Enquiry into Peroperative Deaths 1999 NCEPOD London
   Google Scholar
• Rugg-Gunn , A . 1997 . Scientific validity? . Br. Dent. J. , 182 : 41
   Google Scholar
• Ratliff , TL , Shapiro , A and Catalona , WJ . 1986 . Inhibition of murine bladder tumour growth by Bacillus Calmette–Guerin: lack of a role of natural killer cells . Clin. Immunol. Immunopathol. , 41 : 108 – 115 .
   Google Scholar
• Zbar , B , Bernstein , ID and Rapp , HJ . 1971 . Suppression of tumour growth at the site of infection with living BCG . J. Nat. Cancer Inst. , 46 : 831 – 839 .
   PubMedGoogle Scholar
• Kelly , DR , Ratliff , TL , Catalona , WJ , Shapiro , A , Lage , JM , Bauer , WC , Haaff , EO and Dresner , SM . 1985 . Intravesical Bacillus Calmette–Guerin therapy for superficial bladder cancer. Effect of Bacillus Calmette–Guerin viability on treatment results . J. Urol. , 134 : 48 – 53 .
   Google Scholar
• Griffiths , TRL , Charlton , M , Neal , DE and Powell , PH . 2002 . Treatment of carcinoma in situ . J. Urol. , 167 : 2408 – 2412 .
   PubMed Web of Science ®Google Scholar
• Talic , RF , Hargreave , TB , Bishop , MC , Kirk , D and Prescott , S . 1994 . Intravesical Evans Bacille Calmette–Guerin for carcinoma in situ . Br. J. Urol. , 73 : 645 – 648 .
   PubMedGoogle Scholar
• Messing EM Catalona W 1998 Urothelial tumours of the urinary tract Walsh PC Retik AB Vaughan ED Jr. Wein AJ Campbell's Urology 7th Ed. WB Saunders Philadelphia Chapter 77 2327 2410
   Google Scholar
• Brosman , SA . 1982 . Experience with Bacillus Calmette–Guerin (BCG) in patients with superficial bladder carcinoma . J. Urol. , 128 : 27 – 30 .
   PubMed Web of Science ®Google Scholar
• Bohle , A , Jocham , D and Bock , PR . 2003 . Intravesical Bacillus Calmette–Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity . J. Urol. , 169 : 90 – 95 .
   PubMed Web of Science ®Google Scholar